Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunol Immunother. 2016 Mar; 65(3):247-59.
View in:
PubMed
subject areas
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Humans
Immunologic Memory
Immunotherapy
Inducible T-Cell Co-Stimulator Protein
Interleukin-12
Interleukin-17
Neoplasms
Th17 Cells
T-Lymphocytes, Regulatory
authors with profiles
Chrystal Mary Paulos
Mark P Rubinstein
Xuezhong Yu